Mainland China reported 42 new COVID-19 cases on Tuesday, the highest daily toll in more than two months due to a rise in infections in Xinjiang, the country's health authority said on Wednesday.
Of the new cases, 22 in the city of Kashgar in Xinjiang were previously asymptomatic patients.
The region's health authorities also reported another 19 symptomless infections, which China does not recognise as confirmed COVID-19 cases.
The daily toll marks the highest since 44 confirmed infections were reported on August 10, though it remains far off the peaks in February at the height of the outbreak in mainland China that forced the country into a virtual standstill.
Kashgar health officials said the COVID-19 testing drive for the 4.75 million people in the area was completed as of Tuesday afternoon and a total of 183 people were confirmed to have been infected with the novel coronavirus. The cases are linked to a garment factory, though it's not yet clear how the infections began.
The total number of confirmed COVID-19 infections in mainland China now stands at 85,868, while the death toll remained unchanged at 4,634.
The US objectives in its war against Iran have not changed since strikes started on February 28, Defence Secretary Pete Hegseth said on Thursday, and he accused the media of stirring up concerns that the country risked being locked in an open-ended conflict with shifting priorities.
US President Donald Trump said an angry Israel "violently lashed out" and attacked Iran's major gas field, a significant escalation in the US-Israeli war, but ruled out further such attacks by Israel unless Iran retaliated further.
US President Donald Trump greeted Japan's Prime Minister Sanae Takaichi warmly at the White House on Thursday and said he believed Japan was "really stepping up to the plate" on Iran.
Israel reopened the Rafah crossing with Egypt on Thursday after nearly three weeks to allow some wounded Palestinians to leave for treatment, after Gaza medics said Israeli strikes had killed four people in the enclave.